Terms: = Sarcomas AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393
17 results:
1. Impact of
Fu J; Liu S; Tan Q; Liu Z; Qian J; Li T; Du J; Song B; Li D; Zhang L; He J; Guo K; Zhou B; Chen H; Fu S; Liu X; Cheng J; He T; Fu J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364238
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of positive surgical margins for scalp angiosarcoma.
Kuan CH; Yang HW; Huang HF; Jyuhn-Hsiarn Lee L; Tseng TY; Hsieh JH; Cheng NC; Tai HC; Lai HS
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):217-225. PubMed ID: 32446755
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Composition of Genomic
Krumbholz M; Agaimy A; Stoehr R; Burger M; Wach S; Taubert H; Wullich B; Hartmann A; Metzler M
Dis Markers; 2019; 2019():5085373. PubMed ID: 31915468
[TBL] [Abstract] [Full Text] [Related]
4. Prostatic carcinoma with neuroendocrine differentiation harboring the EWSR1-FEV fusion transcript in a man with the WRN G327X germline mutation: A new variant of prostatic carcinoma or a member of the Ewing sarcoma family of tumors?
Febres-Aldana CA; Krishnamurthy K; Delgado R; Kochiyil J; Poppiti R; Medina AM
Pathol Res Pract; 2020 Feb; 216(2):152758. PubMed ID: 31831298
[TBL] [Abstract] [Full Text] [Related]
5. Integrative clinical transcriptome analysis reveals tmprss2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma.
Gerke JS; Orth MF; Tolkach Y; Romero-Pérez L; Wehweck FS; Stein S; Musa J; Knott MML; Hölting TLB; Li J; Sannino G; Marchetto A; Ohmura S; Cidre-Aranaz F; Müller-Nurasyid M; Strauch K; Stief C; Kristiansen G; Kirchner T; Buchner A; Grünewald TGP
Int J Cancer; 2020 Apr; 146(7):2036-2046. PubMed ID: 31732966
[TBL] [Abstract] [Full Text] [Related]
6. Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types.
van de Stolpe A; Holtzer L; van Ooijen H; Inda MA; Verhaegh W
Sci Rep; 2019 Feb; 9(1):1603. PubMed ID: 30733525
[TBL] [Abstract] [Full Text] [Related]
7. Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer.
Bilke S; Schwentner R; Yang F; Kauer M; Jug G; Walker RL; Davis S; Zhu YJ; Pineda M; Meltzer PS; Kovar H
Genome Res; 2013 Nov; 23(11):1797-809. PubMed ID: 23940108
[TBL] [Abstract] [Full Text] [Related]
8. Recurrent gene fusions in prostate cancer: their clinical implications and uses.
Hessels D; Schalken JA
Curr Urol Rep; 2013 Jun; 14(3):214-22. PubMed ID: 23625457
[TBL] [Abstract] [Full Text] [Related]
9. Morphologic features of carcinomas with recurrent gene fusions.
Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
[TBL] [Abstract] [Full Text] [Related]
10. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
Beltran H; Yelensky R; Frampton GM; Park K; Downing SR; MacDonald TY; Jarosz M; Lipson D; Tagawa ST; Nanus DM; Stephens PJ; Mosquera JM; Cronin MT; Rubin MA
Eur Urol; 2013 May; 63(5):920-6. PubMed ID: 22981675
[TBL] [Abstract] [Full Text] [Related]
11. High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.
Minner S; Luebke AM; Kluth M; Bokemeyer C; Jänicke F; Izbicki J; Schlomm T; Sauter G; Wilczak W
Histopathology; 2012 Sep; 61(3):445-53. PubMed ID: 22463702
[TBL] [Abstract] [Full Text] [Related]
12. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
Brenner JC; Ateeq B; Li Y; Yocum AK; Cao Q; Asangani IA; Patel S; Wang X; Liang H; Yu J; Palanisamy N; Siddiqui J; Yan W; Cao X; Mehra R; Sabolch A; Basrur V; Lonigro RJ; Yang J; Tomlins SA; Maher CA; Elenitoba-Johnson KS; Hussain M; Navone NM; Pienta KJ; Varambally S; Feng FY; Chinnaiyan AM
Cancer Cell; 2011 May; 19(5):664-78. PubMed ID: 21575865
[TBL] [Abstract] [Full Text] [Related]
13. ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.
Scheble VJ; Braun M; Beroukhim R; Mermel CH; Ruiz C; Wilbertz T; Stiedl AC; Petersen K; Reischl M; Kuefer R; Schilling D; Fend F; Kristiansen G; Meyerson M; Rubin MA; Bubendorf L; Perner S
Mod Pathol; 2010 Aug; 23(8):1061-7. PubMed ID: 20473283
[TBL] [Abstract] [Full Text] [Related]
14. Oral manifestations of HIV/AIDS in China: a review.
Zhang X; Reichart PA; Song Y
Oral Maxillofac Surg; 2009 Jun; 13(2):63-8. PubMed ID: 19404695
[TBL] [Abstract] [Full Text] [Related]
15. The discovery of common recurrent transmembrane protease serine 2 (tmprss2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
Shah RB; Chinnaiyan AM
Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
[TBL] [Abstract] [Full Text] [Related]
16. Detection of the tmprss2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data.
Rouzier C; Haudebourg J; Carpentier X; Valério L; Amiel J; Michiels JF; Pedeutour F
Cancer Genet Cytogenet; 2008 May; 183(1):21-7. PubMed ID: 18474293
[TBL] [Abstract] [Full Text] [Related]
17. The effect of delayed postoperative irradiation on local control of soft tissue sarcomas of the extremity and torso.
Schwartz DL; Einck J; Hunt K; Bruckner J; Conrad E; Koh WJ; Laramore GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1352-9. PubMed ID: 11955749
[TBL] [Abstract] [Full Text] [Related]
